Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation

被引：0
|
作者：
Georgios Schoretsanitis
Maxim Kuzin
John M. Kane
Christoph Hiemke
Michael Paulzen
Ekkehard Haen
机构：
[1] Behavioral Health Pavilion,The Zucker Hillside Hospital, Psychiatry Research, Northwell Health
[2] Private Psychiatric Hospital and Academic Teaching Hospital of the University of Zurich,Clienia Schloessli
[3] Zucker School of Medicine at Hofstra/Northwell,Department of Psychiatry and Molecular Medicine
[4] The Feinstein Institute for Medical Research,Center for Psychiatric Neuroscience
[5] University Medical Center of Mainz,Department of Psychiatry and Psychotherapy and Institute of Clinical Chemistry and Laboratory Medicine
[6] Alexianer Hospital Aachen,Department of Psychiatry, Psychotherapy and Psychosomatics
[7] RWTH Aachen University,Department of Psychiatry and Psychotherapy, Clinical Pharmacology
[8] JARA,Department of Pharmacology and Toxicology
[9] Translational Brain Medicine,undefined
[10] University of Regensburg,undefined
[11] University of Regensburg,undefined
来源：
Clinical Pharmacokinetics | 2021年 / 60卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：329 / 335
页数：6
相关论文
共 50 条
  • [1] Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation
    Schoretsanitis, Georgios
    Kuzin, Maxim
    Kane, John M.
    Hiemke, Christoph
    Paulzen, Michael
    Haen, Ekkehard
    [J]. CLINICAL PHARMACOKINETICS, 2021, 60 (03) : 329 - 335
  • [2] Comment on: "Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation"
    Suhas, Satish
    Kumar, Vijay
    Damodharan, Dinakaran
    Sharma, Priyamvada
    Rao, Naren P.
    Varambally, Shivarama
    Venkatasubramanian, Ganesan
    Murthy, Pratima
    Gangadhar, Bangalore N.
    [J]. CLINICAL PHARMACOKINETICS, 2021, 60 (08) : 1073 - 1075
  • [3] Comment on: “Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation”
    Satish Suhas
    Vijay Kumar
    Dinakaran Damodharan
    Priyamvada Sharma
    Naren P. Rao
    Shivarama Varambally
    Ganesan Venkatasubramanian
    Pratima Murthy
    Bangalore N. Gangadhar
    [J]. Clinical Pharmacokinetics, 2021, 60 : 1073 - 1075
  • [4] Authors’ Reply to Suhas et al.: Comment on: “Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation”
    Georgios Schoretsanitis
    Maxim Kuzin
    John M. Kane
    Christoph Hiemke
    Michael Paulzen
    Ekkehard Haen
    [J]. Clinical Pharmacokinetics, 2021, 60 : 1077 - 1079
  • [5] Authors' Reply to Suhas et al.: Comment on: "Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation"
    Schoretsanitis, Georgios
    Kuzin, Maxim
    Kane, John M.
    Hiemke, Christoph
    Paulzen, Michael
    Haen, Ekkehard
    [J]. CLINICAL PHARMACOKINETICS, 2021, 60 (08) : 1077 - 1079
  • [6] Unanticipated plasma concentrations in two clozapine-treated patients
    Alfaro, CL
    McClure, RK
    Vertrees, JE
    Benavides, R
    [J]. ANNALS OF PHARMACOTHERAPY, 2001, 35 (09) : 1028 - 1031
  • [7] Comment: unanticipated plasma concentrations in two clozapine-treated patients
    Lu, ML
    Lang, HY
    Chang, WH
    [J]. ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) : 1675 - 1676
  • [8] Hospital days in clozapine-treated patients
    Dickson, RA
    Dalby, JT
    Williams, R
    Warden, SJ
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1998, 43 (09): : 945 - 948
  • [9] CLOZAPINE-TREATED NMS
    BURRELL, MF
    FEWSTER, C
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1991, 158 : 577 - 577
  • [10] Increased use of antibiotics in clozapine-treated patients
    Landry, P
    Benaliouad, F
    Tessier, S
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (05) : 297 - 298
12345